EWING SARCOMA
Clinical trials for EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA trials appear
Sign up with your email to follow new studies for EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo tackles tough bone cancer
Disease control CompletedThis study tested two drugs, trabectedin and irinotecan, in 37 people with a type of bone cancer called Ewing sarcoma that had come back or not responded to other treatments. The goal was to find a safe dose and see if the combination could shrink tumors. Participants also receiv…
Matched conditions: EWING SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New drug combo shows promise for tough sarcomas in young people
Disease control CompletedThis study tested a combination of two chemotherapy drugs, nab-paclitaxel and gemcitabine, in 59 teenagers and young adults whose sarcoma (a type of bone or soft tissue cancer) had come back or was not responding to standard treatment. The goal was to see if the combo could shrin…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New stem cell approach offers hope for kids with relapsed cancers
Disease control CompletedThis study tested a new type of stem cell transplant in 23 children and young adults with cancers that came back or didn't respond to treatment. The approach uses a special cell filter to speed up immune recovery and reduce risks. The main goal was to see if the transplant was fe…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
Experimental combo targets tough childhood cancers
Disease control CompletedThis study tested a combination of two drugs, olaparib and temozolomide, in 49 adults with Ewing sarcoma or rhabdomyosarcoma that had come back or spread after prior chemotherapy. The goal was to find the safest dose and see if the combo could shrink tumors. While not a cure, the…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 03, 2026 12:07 UTC
-
New hope for young cancer patients: drug shows promise against tough tumors
Disease control CompletedThis study tested the drug lenvatinib in 127 children, adolescents, and young adults whose solid tumors had come back or did not respond to standard treatment. The goal was to see if the drug could shrink tumors and to check for side effects. Participants were grouped by tumor ty…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 01, 2026 17:57 UTC
-
AI mines 700 patient records to uncover sarcoma survival clues
Knowledge-focused CompletedThis study looked back at the electronic health records of 700 people diagnosed with osteosarcoma or Ewing's sarcoma between 2003 and 2012. Researchers used machine learning to find patterns in the data, focusing on how long patients survived. The goal was to learn more about the…
Matched conditions: EWING SARCOMA
Sponsor: University of Milano Bicocca • Aim: Knowledge-focused
Last updated May 26, 2026 12:12 UTC